Narayanam V. Rao

884 total citations
18 papers, 747 citations indexed

About

Narayanam V. Rao is a scholar working on Oncology, Hematology and Emergency Medicine. According to data from OpenAlex, Narayanam V. Rao has authored 18 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Hematology and 4 papers in Emergency Medicine. Recurrent topics in Narayanam V. Rao's work include Peptidase Inhibition and Analysis (5 papers), Hematological disorders and diagnostics (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Narayanam V. Rao is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Hematological disorders and diagnostics (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Narayanam V. Rao collaborates with scholars based in United States, Taiwan and Poland. Narayanam V. Rao's co-authors include John R. Hoidal, Gopna V. Rao, Thomas P. Kennedy, Bruce C. Marshall, Glenn D. Prestwich, Eric Jacquinet, Beulah H. Gray, Kurt H. Albertine, Paul R. Reynolds and Margaret Prechel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Narayanam V. Rao

18 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narayanam V. Rao United States 14 205 170 144 134 105 18 747
Klaus Preissner Germany 17 376 1.8× 200 1.2× 117 0.8× 136 1.0× 300 2.9× 26 1.1k
Valeryi K. Lishko United States 18 243 1.2× 238 1.4× 279 1.9× 116 0.9× 212 2.0× 26 1.1k
Ariel M. Rubinstein Israel 16 629 3.1× 133 0.8× 123 0.9× 155 1.2× 94 0.9× 33 1.3k
S J Suchard United States 13 374 1.8× 161 0.9× 39 0.3× 142 1.1× 98 0.9× 17 705
Justin Sturge United Kingdom 21 745 3.6× 156 0.9× 180 1.3× 316 2.4× 65 0.6× 31 1.4k
Volker Huck Germany 19 240 1.2× 264 1.6× 189 1.3× 46 0.3× 306 2.9× 42 1.1k
Janet Chang United States 16 369 1.8× 524 3.1× 146 1.0× 76 0.6× 27 0.3× 20 998
Sheldon M. Cooper United States 22 359 1.8× 564 3.3× 154 1.1× 44 0.3× 121 1.2× 45 1.8k
Anne C. Rybicki United States 18 481 2.3× 334 2.0× 264 1.8× 38 0.3× 428 4.1× 27 1.7k
Kelvin W. Li United States 18 347 1.7× 81 0.5× 54 0.4× 51 0.4× 30 0.3× 33 1.2k

Countries citing papers authored by Narayanam V. Rao

Since Specialization
Citations

This map shows the geographic impact of Narayanam V. Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narayanam V. Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narayanam V. Rao more than expected).

Fields of papers citing papers by Narayanam V. Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narayanam V. Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narayanam V. Rao. The network helps show where Narayanam V. Rao may publish in the future.

Co-authorship network of co-authors of Narayanam V. Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Narayanam V. Rao. A scholar is included among the top collaborators of Narayanam V. Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narayanam V. Rao. Narayanam V. Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Avery, Stephen, Liqing Xiao, Beverly Torok‐Storb, et al.. (2018). 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia. Blood Advances. 2(7). 754–761. 12 indexed citations
2.
Kovacsovics, Tibor, Alice S. Mims, Mohamed E. Salama, et al.. (2018). Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia. Blood Advances. 2(4). 381–389. 46 indexed citations
3.
Savage, Justin R., Abigail Pulsipher, Narayanam V. Rao, et al.. (2016). A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis. PLoS ONE. 11(6). e0157310–e0157310. 18 indexed citations
4.
Kovacsovics, Tibor, Alice S. Mims, Mohamed E. Salama, et al.. (2016). CX-01, a Low Anticoagulant Heparin, May Enhance Count Recovery and Treatment Efficacy in Acute Myeloid Leukemia. Blood. 128(22). 5220–5220. 4 indexed citations
5.
Kovacsovics, Tibor, Alice S. Mims, Mohamed E. Salama, et al.. (2015). O-desulfated heparin and chemotherapy for the treatment of AML.. Journal of Clinical Oncology. 33(15_suppl). 7053–7053. 3 indexed citations
6.
Suzuki, Akira, Challuri Vijay Kumar, B. Srikanth, et al.. (2014). Synthesis and Characterization of Donor–π‐Acceptor‐Based Porphyrin Sensitizers: Potential Application of Dye‐Sensitized Solar Cells. Chemistry - A European Journal. 20(43). 14074–14083. 21 indexed citations
7.
Fischer, Bernard M., Apparao B. Kummarapurugu, Shuo Zheng, et al.. (2014). 2-O, 3-O-Desulfated Heparin Inhibits Neutrophil Elastase–Induced HMGB-1 Secretion and Airway Inflammation. American Journal of Respiratory Cell and Molecular Biology. 50(4). 684–689. 43 indexed citations
8.
Sharma, Lokesh, Jiao Wu, Vivek Patel, et al.. (2013). Partially-desulfated heparin improves survival inPseudomonaspneumonia by enhancing bacterial clearance and ameliorating lung injury. Journal of Immunotoxicology. 11(3). 260–267. 23 indexed citations
9.
10.
Rao, Narayanam V., Paul R. Reynolds, Jeanine M. Walenga, et al.. (2010). Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. American Journal of Physiology-Cell Physiology. 299(1). C97–C110. 117 indexed citations
11.
Barry, William H., Xiu Q. Zhang, Michael E. Halkos, et al.. (2009). Nonanticoagulant heparin reduces myocyte Na+and Ca2+loading during simulated ischemia and decreases reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology. 298(1). H102–H111. 15 indexed citations
12.
Rao, Narayanam V., et al.. (2005). Kinetics of Ru(III) catalysed oxidation of phenethyl alcohol and para- substituted phenethyl alcohols by Ce(IV) in aqueous nitric acid medium. INDIAN JOURNAL OF CHEMISTRY- SECTION A. 44(1). 80–84. 2 indexed citations
13.
Cutillo, A, David C. Ailion, Suetaro Watanabe, et al.. (2002). Characterization of bleomycin lung injury by nuclear magnetic resonance: Correlation between NMR relaxation times and lung water and collagen content. Magnetic Resonance in Medicine. 47(2). 246–256. 23 indexed citations
14.
Jacquinet, Eric, et al.. (2001). Cloning and characterization of the cDNA and gene for human epitheliasin. European Journal of Biochemistry. 268(9). 2687–2699. 55 indexed citations
15.
Jacquinet, Eric, Narayanam V. Rao, Gopna V. Rao, & John R. Hoidal. (2000). Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin. FEBS Letters. 468(1). 93–100. 36 indexed citations
16.
Rao, Narayanam V., Gopna V. Rao, & John R. Hoidal. (1997). Human Dipeptidyl-peptidase I. Journal of Biological Chemistry. 272(15). 10260–10265. 130 indexed citations
17.
Rao, Narayanam V., Gopna V. Rao, Bruce C. Marshall, & John R. Hoidal. (1996). Biosynthesis and Processing of Proteinase 3 in U937 Cells. Journal of Biological Chemistry. 271(6). 2972–2978. 72 indexed citations
18.
Rao, Narayanam V., Bruce C. Marshall, Beulah H. Gray, & John R. Hoidal. (1993). Interaction of Secretory Leukocyte Protease Inhibitor with Proteinase-3. American Journal of Respiratory Cell and Molecular Biology. 8(6). 612–616. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus Preissner Breakdown of academic impact, for papers by Valeryi K. Lishko Breakdown of academic impact, for papers by Ariel M. Rubinstein Breakdown of academic impact, for papers by S J Suchard Breakdown of academic impact, for papers by Justin Sturge Breakdown of academic impact, for papers by Volker Huck Breakdown of academic impact, for papers by Janet Chang Breakdown of academic impact, for papers by Sheldon M. Cooper Breakdown of academic impact, for papers by Anne C. Rybicki Breakdown of academic impact, for papers by Kelvin W. Li
Rankless by CCL
2026